{"title": "COVID-19 Vaccine Toolkit", "author": null, "url": "https://www.cms.gov/covidvax-provider", "hostname": "cms.gov", "description": "The COVID-19 public health emergency (PHE) ended at the end of the day on May 11, 2023. View Infectious diseases for a list of waivers and flexibilities that were in place during the PHE.", "sitename": "cms.gov", "date": "2023-08-09", "cleaned_text": "COVID-19 Vaccine Toolkit The COVID-19 public health emergency (PHE) ended at the end of the day on May 11, 2023. View [Infectious diseases](/about-cms/agency-information/emergency/epro/past-emergencies/infectious-diseases) for a list of waivers and flexibilities that were in place during the PHE. This toolkit is for health care providers. Review this page for information about the Medicare COVID-19 Vaccines Toolkit during and after the PHE. If you're a person with Medicare, learn more about your [Medicare coverage for COVID-19 vaccines](https://www.medicare.gov/medicare-coronavirus), and [find a COVID-19 vaccine near you](https://www.vaccines.gov/). This COVID-19 Vaccine Toolkit is for health care providers and includes information to describe: [The COVID-19 vaccine Medicare coding structure](/medicare/payment/covid-19/coding-covid-19-vaccine-shots) [Medicare payment rates for administering COVID-19 vaccines](/medicare/payment/covid-19/medicare-covid-19-vaccine-shot-payment), including a timeline of FDA approvals and EUA amendments for COVID-19 vaccines [How to bill correctly for administering vaccines, including roster and centralized billing](/medicare/payment/covid-19/medicare-billing-covid-19-vaccine-shot-administration) [Monoclonal antibody infusion for treating COVID-19](/monoclonal) [New COVID-19 Treatments Add-on Payment (NCTAP)](/medicare/payment/covid-19/new-covid-19-treatments-add-payment-nctap) If you have questions about billing or reimbursement of vaccine administration for patients covered by private insurance or Medicaid, contact the respective health plan or [state Medicaid agency](https://www.medicaid.gov/about-us/contact-us/contact-your-state-questions). | | Note: | | Patients who are moderately or severely immunocompromised (have a weakened immune system) are at increased risk of severe COVID-19 illness and death. And, the immune response following COVID-19 vaccination may differ for these patients. Learn about "}